Anti-CD47 Antibody (Magrolimab)
Catalog No.
F1222
Anti-CD47 Antibody (Magrolimab)
Featured Products
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 antibody. Magrolimab blocks the "don't eat me" signal of CD47, thereby promoting macrophage-mediated phagocytosis. Magrolimab has antitumor activity in malignant bone tumors and breast cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.74 kDa
Dry ice
2169232-81-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Hu5F9-G4
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q08722
Human, Mouse
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Magrolimab inhibited the tumor growth of Raji on NOD.SCID mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 90.0% at 5 mpk at D32.
CD47
Please avoid freeze-thaw cycles.